Prevalence and predictors of non-fatal myocardial infarction in Jordan
AbstractThis study in May 2002, part of the Jordan Department of Statistics national crosssectional, multistage employment and unemployment survey, measured the prevalence of selfreported myocardial infarction [MI] and the association with modifiable risk factors among Jordanians aged 40+ years. Of 3083 participants, 183 [5.9%] had ever been told by a doctor that they had had a MI. The prevalence varied by age and sex; 128 [69.9%] of the cases were in men. Among males and females, self-reported hypertension and hypercholesterolaemia were significantly associated with MI and diabetes was a significant risk factor for women. There was a significant relationship between current smoking and MI but not with previous smoking. Exercise and body mass index were not statistically significant predictors of MI in both males and females
Nsour, N., Mahfoud, Z., Kanaan, M.N. & Balbeissi, A. (2008). Prevalence and predictors of non-fatal myocardial infarction in Jordan. EMHJ - Eastern Mediterranean Health Journal, 14 (4), 818-830, 2008 http://www.who.int/iris/handle/10665/117499
JournalEMHJ - Eastern Mediterranean Health Journal, 14 (4), 818-830, 2008
MetadataShow full item record
Showing items related by title and MeSH subject.
Interpretation of symptoms as a cause of delays in patients with acute myocardial infarction, Istanbul, Turkey Koc, Sema; Durna, Zehra; Akin, Semiha (2017-04)This cross-sectional study aimed to assess interpretation of symptoms as a cause of delays in patients with acute myocardial infarction [AMI]. It was conducted at a university hospital in Istanbul, Turkey. The sample included 93 patients: 73 male, mean age 57.89 [12.13] years. Prehospital delay time ranged from 15 minutes to 10 days, with a median of 2 hours [interquartile range: 9.50]. Patients waited for pain to go away [48.4%] and tried to calm down [39.8%]. Most patients attributed AMI-related symptoms to a reason other than heart disease. ...
Guide technique pour la prise en charge des maladies cardiovasculaires dans le cadre des soins de santé primaires : accès aux médicaments essentiels et aux technologies de santé de base Organisation mondiale de la Santé (WHO/NMH/NVI/18.3, 2018)